feed,title,long_url,short_url
Motley,Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?,https://www.fool.com/investing/2022/05/23/could-this-biosimilar-drug-be-a-blockbuster-amgen/?source=iedfolrf0000001,https://bit.ly/3wMKXyW
